KLF17P2

Across TCGA pan-cancer cohorts, KLF17P2 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated KLF17P2 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher KLF17P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated KLF17P2 expression acts as an unfavorable survival marker, although some lineages such as ACC show a favorable association.

ACC, THYM, and LGG are the cancer types where KLF17P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	III,IV	0.692	0.180	.001	84	view →
THYM	OS	Tertile	All	0.039	0.928	<.001	54	view →
LGG	OS	Tertile	All	0.850	0.932	.002	27	view →
BLCA	DFS	Tertile	All	0.218	0.512	.030	18	view →
TGCT	DFS	Tertile	All	0.372	0.700	.016	18	view →
PRAD	OS	Tertile	All	0.816	0.990	<.001	18	view →
LIHC	OS	Tertile	All	0.184	0.570	.005	15	view →
KIRP	DFS	Tertile	All	0.729	0.874	.009	15	view →
SARC	OS	Tertile	All	0.259	0.634	<.001	9	view →
LUAD	OS	Tertile	II,III,IV	0.247	0.680	.042	9	view →
LUSC	DFS	Tertile	II,III,IV	0.199	0.748	.006	9	view →
KIRC	DFS	Tertile	IV	0.163	0.357	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

KLF17P2–ACC (DFS)

Open the ACC breakdown →